Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exscientia Plc - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

3 Med Tech Stocks That the AI Boom Will Only Help ↗

September 07, 2023

Med tech stocks are integrating artificial intelligence, adding substantial value for patients and investors in the near future.

Via InvestorPlace

Topics Artificial Intelligence

Exscientia to Present at Upcoming Investor Conferences in September

August 31, 2023

From Exscientia plc

Via Business Wire

Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries ↗

August 23, 2023

Here are just a few top biotech stocks that may be on the cusp of major, game-changing discoveries, thanks to AI.

Via InvestorPlace

Exscientia Business Update for Second Quarter and First Half of 2023

August 10, 2023

From Exscientia plc

Via Business Wire

A Preview Of Exscientia's Earnings ↗

August 09, 2023

Via Benzinga

The Latest Analyst Ratings for Exscientia ↗

July 20, 2023

Via Benzinga

4 Analysts Have This to Say About Exscientia ↗

June 26, 2023

Via Benzinga

Why Shares of Exscientia Soared This Week ↗

May 26, 2023

The company benefited from a surge in interest in AI-associated stocks.

Via The Motley Fool

Exscientia: Q1 Earnings Insights ↗

May 24, 2023

Via Benzinga

3 AI Stocks Billionaires Are Loading Up On ↗

August 04, 2023

With investors pouring funds into AI, it makes sense to consider snapping up the top AI stocks billionaires buy.

Via InvestorPlace

Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023

August 03, 2023

From Exscientia

Via Business Wire

Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

August 01, 2023

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

Via MarketBeat

Topics Artificial Intelligence

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes ↗

July 30, 2023

Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.

Via InvestorPlace

MarketBeat Week in Review – 7/24 - 7/28

July 29, 2023

Investors continue to look for stocks to buy as inflation cools. As you prepare for another busy week, here are some of our top stories from this week

Via MarketBeat

Topics Economy

Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential

July 28, 2023

A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.

Via MarketBeat

Topics Artificial Intelligence

Exscientia is the Sniper of the AI Drug Discovery Industry

July 27, 2023

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

Via MarketBeat

Topics Artificial Intelligence

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 25, 2023

It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗

July 21, 2023

Via Benzinga

Exscientia Initiates Prospective Observational Study in Ovarian Cancer

July 18, 2023

From Exscientia

Via Business Wire

3 Biotech Stocks Using AI to Change Healthcare Forever ↗

July 14, 2023

These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past.

Via InvestorPlace

Why Shares of Exscientia Jumped on Wednesday ↗

July 12, 2023

The company may be riding the wave of an AI healthcare boom.

Via The Motley Fool

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours

July 10, 2023

From Exscientia plc

Via Business Wire

Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday ↗

July 06, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Exscientia Announces Expansion of its Technology Leadership Team

June 29, 2023

From Exscientia

Via Business Wire

Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 06, 2023

From Exscientia plc

Via Business Wire

3 Pharma Stocks That Will Boom Thanks to AI ↗

May 26, 2023

Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms.

Via InvestorPlace

Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today ↗

May 24, 2023

With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede.

Via The Motley Fool

Earnings Scheduled For May 24, 2023 ↗

May 24, 2023

Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.